Sterling Capital Management LLC Supernus Pharmaceuticals, Inc. Transaction History
Sterling Capital Management LLC
- $7.3 Trillion
- Q4 2024
A detailed history of Sterling Capital Management LLC transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Sterling Capital Management LLC holds 14,562 shares of SUPN stock, worth $464,673. This represents 0.01% of its overall portfolio holdings.
Number of Shares
14,562
Previous 167
8619.76%
Holding current value
$464,673
Previous $5.21 Million
10012.58%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding SUPN
# of Institutions
303Shares Held
60.6MCall Options Held
22.3KPut Options Held
6K-
Black Rock Inc. New York, NY10.4MShares$332 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.15MShares$196 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY4.84MShares$154 Million2.47% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.88MShares$91.9 Million0.03% of portfolio
-
Macquarie Group LTD Australia, C32.63MShares$83.9 Million0.11% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $1.71B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...